BRPI1009221A2 - proteínas de fusão transcriptase reversa estabilizadas. - Google Patents

proteínas de fusão transcriptase reversa estabilizadas.

Info

Publication number
BRPI1009221A2
BRPI1009221A2 BRPI1009221A BRPI1009221A BRPI1009221A2 BR PI1009221 A2 BRPI1009221 A2 BR PI1009221A2 BR PI1009221 A BRPI1009221 A BR PI1009221A BR PI1009221 A BRPI1009221 A BR PI1009221A BR PI1009221 A2 BRPI1009221 A2 BR PI1009221A2
Authority
BR
Brazil
Prior art keywords
fusion proteins
reverse transcriptase
transcriptase fusion
stabilized reverse
stabilized
Prior art date
Application number
BRPI1009221A
Other languages
English (en)
Inventor
Alan M Lambowitz
Eman Ghanem
Sabine Mohr
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BRPI1009221A2 publication Critical patent/BRPI1009221A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241Nucleotidyltransferases (2.7.7)
    • C12N9/1276RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07Nucleotidyltransferases (2.7.7)
    • C12Y207/07049RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/24Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1009221A 2009-03-04 2010-03-04 proteínas de fusão transcriptase reversa estabilizadas. BRPI1009221A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15733209P 2009-03-04 2009-03-04
PCT/US2010/026165 WO2010102085A2 (en) 2009-03-04 2010-03-04 Stabilized reverse transcriptase fusion proteins

Publications (1)

Publication Number Publication Date
BRPI1009221A2 true BRPI1009221A2 (pt) 2016-03-15

Family

ID=42710216

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009221A BRPI1009221A2 (pt) 2009-03-04 2010-03-04 proteínas de fusão transcriptase reversa estabilizadas.

Country Status (11)

Country Link
US (4) US10113156B2 (pt)
EP (2) EP3415621A1 (pt)
JP (2) JP5882064B2 (pt)
CN (1) CN102421791A (pt)
AU (1) AU2010221284B2 (pt)
BR (1) BRPI1009221A2 (pt)
CA (1) CA2754476A1 (pt)
IL (1) IL214913A (pt)
MX (1) MX2011009205A (pt)
WO (1) WO2010102085A2 (pt)
ZA (1) ZA201107207B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101818126B1 (ko) * 2011-02-09 2018-01-15 (주)바이오니아 열안정성이 증가된 역전사효소
WO2012116146A1 (en) * 2011-02-23 2012-08-30 Board Of Regents Use of template switching for dna synthesis
IL310721A (en) 2015-10-23 2024-04-01 Harvard College Nucleobase editors and their uses
WO2017100177A1 (en) * 2015-12-07 2017-06-15 Bio-Rad Laboratories, Inc. Dimeric reverse transcriptase
CA3032699A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harvard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
CN110214180A (zh) 2016-10-14 2019-09-06 哈佛大学的校长及成员们 核碱基编辑器的aav递送
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
US11542496B2 (en) 2017-03-10 2023-01-03 President And Fellows Of Harvard College Cytosine to guanine base editor
CN110914426A (zh) 2017-03-23 2020-03-24 哈佛大学的校长及成员们 包含核酸可编程dna结合蛋白的核碱基编辑器
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US11319532B2 (en) 2017-08-30 2022-05-03 President And Fellows Of Harvard College High efficiency base editors comprising Gam
WO2019070843A1 (en) * 2017-10-03 2019-04-11 Board Of Regents, The University Of Texas System INVERSE TRANSCRIPTASE WITH LTR-FREE BACKLIGHTS AND USES THEREOF
AU2018352592A1 (en) 2017-10-16 2020-06-04 Beam Therapeutics, Inc. Uses of adenosine base editors
AU2020242032A1 (en) 2019-03-19 2021-10-07 Massachusetts Institute Of Technology Methods and compositions for editing nucleotide sequences
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
JP2023543803A (ja) 2020-09-24 2023-10-18 ザ ブロード インスティテュート,インコーポレーテッド プライム編集ガイドrna、その組成物、及びその使用方法
WO2022150790A2 (en) 2021-01-11 2022-07-14 The Broad Institute, Inc. Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
WO2023015309A2 (en) 2021-08-06 2023-02-09 The Broad Institute, Inc. Improved prime editors and methods of use
WO2023076898A1 (en) 2021-10-25 2023-05-04 The Broad Institute, Inc. Methods and compositions for editing a genome with prime editing and a recombinase
WO2023102538A1 (en) 2021-12-03 2023-06-08 The Broad Institute, Inc. Self-assembling virus-like particles for delivery of prime editors and methods of making and using same
WO2023205687A1 (en) 2022-04-20 2023-10-26 The Broad Institute, Inc. Improved prime editing methods and compositions
WO2023240137A1 (en) 2022-06-08 2023-12-14 The Board Institute, Inc. Evolved cas14a1 variants, compositions, and methods of making and using same in genome editing
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
WO2024108092A1 (en) 2022-11-17 2024-05-23 The Broad Institute, Inc. Prime editor delivery by aav

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5654176A (en) 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
US5736373A (en) * 1996-09-23 1998-04-07 Becton, Dickinson And Company Thermostable DNA polymerase from Bacillus pallidus
US7001745B1 (en) 1998-09-30 2006-02-21 New England Biolabs, Inc. Intein mediated peptide ligation
US6436677B1 (en) 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
US6627424B1 (en) * 2000-05-26 2003-09-30 Mj Bioworks, Inc. Nucleic acid modifying enzymes
CA2453986A1 (en) * 2001-07-18 2003-01-30 Merck Patent Gesellschaft Mit Beschraenkter Haftung Glycoprotein vi fusion proteins
US7670807B2 (en) * 2004-03-10 2010-03-02 East Tennessee State Univ. Research Foundation RNA-dependent DNA polymerase from Geobacillus stearothermophilus
WO2006020868A2 (en) * 2004-08-13 2006-02-23 New England Biolabs, Inc. Intracellular production of a nuclease

Also Published As

Publication number Publication date
US20120009630A1 (en) 2012-01-12
EP2403941B1 (en) 2018-10-03
JP5882064B2 (ja) 2016-03-09
JP2015193666A (ja) 2015-11-05
US20180340158A1 (en) 2018-11-29
US20160289652A1 (en) 2016-10-06
EP2403941A4 (en) 2012-09-05
CN102421791A (zh) 2012-04-18
JP2012519489A (ja) 2012-08-30
CA2754476A1 (en) 2010-09-10
MX2011009205A (es) 2011-09-30
AU2010221284B2 (en) 2015-10-01
WO2010102085A4 (en) 2011-01-06
US10113156B2 (en) 2018-10-30
US10150955B2 (en) 2018-12-11
IL214913A0 (en) 2011-11-30
IL214913A (en) 2017-06-29
ZA201107207B (en) 2012-12-27
WO2010102085A2 (en) 2010-09-10
US20180346890A1 (en) 2018-12-06
WO2010102085A3 (en) 2010-11-18
AU2010221284A1 (en) 2011-10-27
EP2403941A2 (en) 2012-01-11
EP3415621A1 (en) 2018-12-19
US10858636B2 (en) 2020-12-08

Similar Documents

Publication Publication Date Title
BRPI1009221A2 (pt) proteínas de fusão transcriptase reversa estabilizadas.
BRPI0813452A2 (pt) protéinas de fusão rage.
BRPI0820114A2 (pt) Engenharia de proteínas enzimaticamente suscetíveis
BRPI1011134A2 (pt) turbomáquina.
BRPI1010653A2 (pt) refrigerador.
DK3118221T3 (da) Proteiner
CL2007002227S1 (es) Botella.
BR112012000281A2 (pt) proteína quimérica.
CL2008001030S1 (es) Botella.
BRPI0924633A2 (pt) refrigerador.
IT1396487B1 (it) Convogliatore.
BRPI1016192A2 (pt) derivados de soxazol.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
CL2008000591S1 (es) Botella.
BR112012014495A2 (pt) cosmético de autonivelamento.
BRPI1014244A2 (pt) composto de polipropileno-talco estabilizado.
IT1396642B1 (it) Statore.
ES1066333Y (es) Reloj de pulsera.
FR2918847B1 (fr) Kimono.
CL2007002937S1 (es) Botella.
FR2935263B1 (fr) Cotyle prothetique articulaire.
FR2943510B1 (fr) Ombrelle.
FR2946591B1 (fr) Sur-tapis eclairant.
IT1396118B1 (it) Composizione dolcificante.
DK2219663T3 (da) Revers-protein

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.